Access to orphan drugs in western Europe: can more systematic policymaking really help to avoid different decisions about the same drug?

Tim Kanters, Leona Hakkaart - van Roijen, Maureen Rutten - van Molken, Ken Redekop

Health Technology Assessment (HTA)

Research output: Contribution to journal › Article › Academic › peer-review

9 Citations (Scopus)

Original language	English
Pages (from-to)	557-559
Number of pages	3
Journal	Expert review of pharmacoeconomics & outcomes research
Volume	15
Issue number	4
DOIs	https://doi.org/10.1586/14737167.2015.1045882
Publication status	Published - 2015

Access to Document

10.1586/14737167.2015.1045882

http://hdl.handle.net/1765/83611

Cite this

@article{6226de04becb4cc386ceff1d35083edc,

title = "Access to orphan drugs in western Europe: can more systematic policymaking really help to avoid different decisions about the same drug?",

author = "Tim Kanters and {Hakkaart - van Roijen}, Leona and {Rutten - van Molken}, Maureen and Ken Redekop",

year = "2015",

doi = "10.1586/14737167.2015.1045882",

language = "English",

volume = "15",

pages = "557--559",

journal = "Expert Review of Pharmacoeconomics and Outcomes Research",

issn = "1473-7167",

publisher = "Taylor & Francis Ltd",

number = "4",

}

Access to orphan drugs in western Europe: can more systematic policymaking really help to avoid different decisions about the same drug? / Kanters, Tim ; Hakkaart - van Roijen, Leona ; Rutten - van Molken, Maureen et al.

In: Expert review of pharmacoeconomics & outcomes research, Vol. 15, No. 4, 2015, p. 557-559.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Access to orphan drugs in western Europe: can more systematic policymaking really help to avoid different decisions about the same drug?

AU - Kanters, Tim

AU - Hakkaart - van Roijen, Leona

AU - Rutten - van Molken, Maureen

AU - Redekop, Ken

PY - 2015

Y1 - 2015

U2 - 10.1586/14737167.2015.1045882

DO - 10.1586/14737167.2015.1045882

M3 - Article

VL - 15

SP - 557

EP - 559

JO - Expert Review of Pharmacoeconomics and Outcomes Research

JF - Expert Review of Pharmacoeconomics and Outcomes Research

SN - 1473-7167

IS - 4

ER -